BURKE STEVEN KEITH (SVP, Chief Medical Officer) sold 6.7% of their position (67.66K shares) of AKEBIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $94.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/4/2026ACC: 0001619834-26-000002
Officer· SVP, Chief Medical Officer
Since Aug 2019
-67.66K
Net shares
Net seller
$94.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
67.66K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−21.58K
Price / share
$1.39
Trade value
$30K
% of position
2.1%
2/2/2026
1.02M→994.51K
Common Stock
Direct
Shares
−25.38K
Price / share
$1.39
Trade value
$35.27K
% of position
2.6%
2/2/2026
994.51K→969.13K
Common Stock
Direct
Shares
−20.70K
Price / share
$1.39
Trade value
$28.77K
% of position
2.1%
2/2/2026
969.13K→948.43K
Total
Net shares
−67.66K
Net value
-$94.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −21.58K | $1.39 | $30K | 2.1% | 1.02M | 994.51K |
| Common Stock Direct | 2/2/2026 | S · Sale | −25.38K | $1.39 | $35.27K | 2.6% | 994.51K | 969.13K |
| Common Stock Direct | 2/2/2026 | S · Sale | −20.70K | $1.39 | $28.77K | 2.1% | 969.13K | 948.43K |
| Total | −67.66K | -$94.04K | ||||||
Derivative Transactions0
No derivative transactions reported